CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) today announced additional positive interim results for the ongoing single ascending dose portion of the Phase 1 study ...

More than 70% of downloaded mobile apps are abandoned after just one use. Companies invest heavily in app creation, but their apps can’t engage users. In this article, we’ll guide you through the main ...

We hear a lot of ideas for apps at my company. People from large enterprises and small startups, located all over the world, call us to explore their mobile and web-based application ideas, and one of ...

SDLC guides teams to plan, build, test, and deliver software. Discover phases, KPIs, tools, and checklist with our quick start guide. Picture this: You and your team have spent a tremendous amount of ...

Application security posture management company Apiiro Ltd. today announced a new artificial intelligence-driven capability that automatically analyzes feature requests to identify risks and ...

– First Patient Dosed in Multiple-dose Part B Portion of Study, with the Study Proceeding in Canada, UK, and the Netherlands – CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq ...